Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
13.21
+0.33 (2.56%)
Jun 12, 2025, 1:48 PM - Market open
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $920.52 million as of June 12, 2025. Its market cap has increased by 49.31% in one year.
Market Cap
920.52M
Enterprise Value
613.19M
1-Year Change
49.31%
Ranking
Category
Stock Price
$13.21
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $920.52M, an increase of 179.45%. That is a compound annual growth rate of 13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 897.50M | -11.00% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.65B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |